Home › Occupations › Chemists › Watertown, MA
Chemists in Watertown, MA: H-1B salaries
24 labor condition applications for this occupation with a work site in Watertown, MA. Median offered base salary $117,206; middle half $105,851–$139,375.
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $81,600 |
| Level II (qualified) | $105,851 |
| Level III (experienced) | $124,093 |
| Level IV (fully competent) | $176,799 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| Tome Biosciences Inc. | 4 | $90,800 |
| Foghorn Therapeutics, Inc | 4 | $117,312 |
| Novo Nordisk, Inc. | 3 | $198,187 |
| Orna Therapeutics, Inc. | 3 | $150,900 |
| C4 Therapeutics, Inc. | 2 | $142,792 |
| Enanta Pharmaceuticals, Inc. | 2 | $116,917 |
| Parallel Squared Technology Institute, LLC | 2 | $115,000 |
| Disc Medicine, Inc. | 1 | $137,500 |
| EyePoint Pharmaceuticals US, Inc. | 1 | $120,000 |
| Prime Medicine, Inc. | 1 | $140,000 |
| Souffle Therapeutics, Inc. | 1 | $97,760 |
Job titles
- Senior Research Associate, Analytical Development4
- Associate Director, Formulation Development2
- Senior Scientist2
- Mass Spectrometry Scientist II2
- Scientist2
- Principal Research Associate2
- Senior Research Scientist1
- Scientist II Small Molecule CMC (OSDs)1
- Sr Associate Scientist1
- Senior Scientist - Process Chemistry1
- Scientist II, Oligonucleotide Chemistry1
- Associate Director - Quality Control1
- Associate Scientist II, Peptide Chemistry1
- Principal Scientist1
- Associate Scientist1
H-1B sponsors in Watertown, MA →
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).